Clinical Trial Update: Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing AEB071 (sotrastaurin) to cyclosporine in kidney transplant recipients to evaluate efficacy, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• AEB071 (sotrastaurin)
• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED